Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?

Yamada R, Maeda N, Oguri H, Adachi Y, Takeuchi T, Furihata M, Fukaya T.

Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):96-100. doi: 10.1016/j.ejogrb.2013.08.003. Epub 2013 Aug 9.

PMID:
24017961
2.
3.

p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.

Lee JH, Kang YS, Park SY, Kim BG, Lee ED, Lee KH, Park KB, Kavanagh JJ, Wharton JT.

Cancer Genet Cytogenet. 1995 Nov;85(1):43-50.

PMID:
8536236
4.

p53 mutation is infrequent in clear cell carcinoma of the ovary.

Ho ES, Lai CR, Hsieh YT, Chen JT, Lin AJ, Hung MH, Liu FS.

Gynecol Oncol. 2001 Feb;80(2):189-93.

PMID:
11161858
5.

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

Okuda T, Otsuka J, Sekizawa A, Saito H, Makino R, Kushima M, Farina A, Kuwano Y, Okai T.

Gynecol Oncol. 2003 Mar;88(3):318-25.

PMID:
12648581
6.

p53 mutations in ovarian cancer: a late event?

Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C.

Oncogene. 1991 Sep;6(9):1685-90.

PMID:
1923532
7.

p53 mutation in carcinomas arising in ovarian cystic teratomas.

Fujii T, Oguni S, Kikuchi M, Kanai N, Saito K.

Pathol Int. 1995 Sep;45(9):649-54.

PMID:
8548037
8.

Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.

Hietanen SH, Kurvinen K, Syrjänen K, Grénman S, Carey T, McClatchey K, Syrjänen S.

Am J Obstet Gynecol. 1995 Nov;173(5):1477-82.

PMID:
7503188
9.

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.

Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ.

Cancer Res. 1993 Jul 1;53(13):3103-8.

10.

The role of p53 mutation in the carcinomas arising from endometriosis.

Akahane T, Sekizawa A, Purwosunu Y, Nagatsuka M, Okai T.

Int J Gynecol Pathol. 2007 Jul;26(3):345-51.

PMID:
17581423
11.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
12.

Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.

Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM.

Int J Gynecol Pathol. 2012 Jul;31(4):297-303. doi: 10.1097/PGP.0b013e31823f8482.

13.

Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.

Liu FS, Kohler MF, Marks JR, Bast RC Jr, Boyd J, Berchuck A.

Obstet Gynecol. 1994 Jan;83(1):118-24.

PMID:
8272291
14.

A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.

Dahiya R, Deng G, Selph C, Carroll P, Presti J Jr.

Biochem Mol Biol Int. 1998 Feb;44(2):407-15.

PMID:
9530523
15.

p53 tumor suppressor gene mutation in ovarian cancer in Thai patients.

Neungton N, Neungton S, Leelaphatanadit C, Dangrat C, Soiampornkul R.

J Med Assoc Thai. 2002 Jun;85(6):658-67.

PMID:
12322838
16.

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.

Laframboise S, Chapman W, McLaughlin J, Andrulis IL.

Cancer J. 2000 Sep-Oct;6(5):302-8.

PMID:
11079169
17.
18.

The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.

Papadaki H, Finkelstein SD, Kounelis S, Bakker A, Swalsky PA, Kapadia SB.

Hum Pathol. 1996 Jun;27(6):567-72.

PMID:
8666366
19.

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A.

J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9.

PMID:
8360934
20.

Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.

Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y, Mori T.

Jpn J Cancer Res. 1992 Oct;83(10):1030-6.

PMID:
1333465

Supplemental Content

Support Center